세미나안내

[2017 03 22] 정기세미나 3rd

The Origins and Evolution of Controlled Drug Delivery Systems Using Biomaterials

관리자 | 2017.03.20 09:28 | 조회 1182


 

 

The Origins and Evolution of Controlled Drug Delivery

Systems Using Biomaterials

 

 

 Date: 2017. 03. 22(Wed), 12:30 ~

 Place: Auditorium (1F) at POSTECH Biotech Center (생명공학센터, 1층 대강당(182)

(Time and venue changed)

 Speaker: Prof. Allan Hoffman (University of Washington)

Host of a Seminar: Prof. Sei Kwang Hahn

 

Speaker Language: ENGLISH

 

Abstract:

 

The idea to conjugate PEG [poly(ethyleneglycol)] to a protein, i.e., to “PEGylate” a protein, was first proposed by Prof. Frank Davis (Rutgers Univ.) in the late 1960s-early 1970s. (1) He wanted to make the new recombinant proteins less immunogenic in our bodies, and thereby enhance their circulation and activity lifetimes. He thought that if he could conjugate a hydrophilic polymer to the “new” protein, it might not be recognized by the immune system as a foreign molecule. Davis further said that he discovered mPEG (methoxy-PEG) in a “company catalog”, and he proposed to conjugate the one, reactive –PEG-OH end group to the protein.  He asked his PhD student, Abraham Abuchowski, to work on it. Abuchowski chose an enzyme, bovine liver catalase, as his model protein. He subsequently found that the PEGylated protein did indeed have reduced immunogenicity, along with a longer circulation lifetime. They published their results in J Biol Chem in 1977 and they continued to actively publish articles on PEGylated proteins (e.g., 2).  In 1981 Abuchowski founded the first “PEGylation” company, which he and colleagues called Enzon®, to make and sell PEGylated proteins to pharmaceutical companies. Abuchowski was the founding President and CEO of Enzon. Frank Davis was an Advisor to Enzon and later, after he retired, he became a Vice President of Enzon.

Meanwhile, in the 1970s others were interested in “biocompatible” biomaterials that would be used in contact with body fluids such as blood. Prof. Edward W. Merrill in the Chemical Engineering Dept. at MIT was preparing lightly crosslinked hydrogels of PEO, and he published a seminal article in 1983 entitled “Polyethylene Oxide as a Biomaterial”, in which he said:  “Cumulative evidence indicates a very low level of interaction between polyethylene oxide and biological species studied (molecular, cellular). Thus this polymer is potentially important as a biomaterial”. (3)

This talk will review this early history of PEGylation, and will also describe the latest findings and current state of the art of PEGylation of drugs and biomaterial surfaces.

References:  (1) F.F. Davis, ADDR, 54 (2002) 457-458

(2) A. Abuchowski, J Biol Chem, 252 (1977) 3578-3581

(3) E.W. Merrill, ASAIO J, 6, (1983) 60


Dept. of MSE / CITE / BK21+





156개(1/8페이지)
세미나안내
번호 제목 글쓴이 조회 날짜
156 [2017 04 24]포스텍-POSCO기술연구소 연구분야 포럼 사진 첨부파일 관리자 55 2017.04.20 11:31
155 [2017 04 19] 정기세미나 6th 첨부파일 관리자 75 2017.04.17 10:24
154 [2017 04 05] 정기세미나 5th 첨부파일 관리자 128 2017.04.03 09:08
153 [2017 03 29] 정기세미나 4th 첨부파일 관리자 5408 2017.03.27 11:50
>> [2017 03 22] 정기세미나 3rd 첨부파일 관리자 1183 2017.03.20 09:28
151 [2017 03 15] 정기세미나 2nd 첨부파일 관리자 2366 2017.03.13 09:16
150 [2017 03 09] 특별세미나 Ph.D Rishi Raj 첨부파일 관리자 1500 2017.03.07 15:32
149 [2017 03 08] 정기세미나 1st 첨부파일 관리자 204 2017.03.07 09:13
148 [2017 02 22] 신소재공학과 특별세미나 첨부파일 관리자 214 2017.02.22 09:21
147 [2016 12 14] 정기세미나 12th 첨부파일 관리자 29003 2016.12.12 13:04
146 [2016 12 07] 정기세미나 11th 첨부파일 관리자 494 2016.12.05 09:11
145 [2016 11 30] 정기세미나 10th 첨부파일 관리자 568 2016.11.28 16:48
144 [2016 11 23] 정기세미나 9th 첨부파일 관리자 5669 2016.11.07 09:18
143 [2016 11 16] 정기세미나 8th 첨부파일 관리자 377 2016.11.07 09:18
142 [2016 11 15] 특별세미나 Ph.D Yadong Yin (Univ 첨부파일 관리자 325 2016.11.07 09:23
141 [2016 11 09] 정기세미나 7th 첨부파일 관리자 382 2016.11.07 09:18
140 [2016 11 02] 정기세미나 6th 첨부파일 관리자 366 2016.10.31 09:44
139 [2016 10 19] 정기세미나 5th 관리자 453 2016.10.17 15:32
138 [2016 10 12] 정기세미나 4th 첨부파일 관리자 347 2016.10.10 10:41
137 [2016 10 05] 정기세미나 3rd 첨부파일 관리자 425 2016.10.04 09:04